Disease, temporal and sociodemographic influences on initial treatment of community-acquired pneumonia in Manitoba, Canada

International Journal of Antimicrobial Agents

Volumn 28, Issue 2, 2006, Pages 95-100

  Carrie, Anita G ^a   Kozyrskyj, Anita L ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antibacterial agents; Canada; Hospitalisation; Pharmaceutical services; Pneumonia

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; CANADA; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DATA ANALYSIS; DEMOGRAPHY; EMERGENCY WARD; FAMILY; GENDER; HEALTH CARE; HEALTH INSURANCE; HOME; HOSPITALIZATION; HUMAN; INCOME; OUTPATIENT; POPULATION RESEARCH; PRIORITY JOURNAL; REIMBURSEMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; URBAN POPULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HOSPITALIZATION; HUMANS; INCOME; INSURANCE CLAIM REPORTING; MALE; MANITOBA; MIDDLE AGED; PNEUMONIA; SOCIOECONOMIC FACTORS;

EID: 33746300237     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.02.022     Document Type: Article

References (24)

1. LeLorier J., and Derderian F. Effect of listing ciprofloxacin in provincial formularies on hospitalizations for bronchitis and pyelonephritis. Can J Clin Pharmacol 5 (1998) 133-137
2. Marra F., Patrick D.M., White R., Ng H., Bowie W.R., and Hutchinson J.M. Effect of formulary policy decisions on antimicrobial drug utilization in British Columbia. J Antimicrob Chemother 55 (2005) 95-101
3. Sketris I.S., Metge C., Shevchuk Y., et al. Comparison of anti-infective drug use in elderly persons in Manitoba, Nova Scotia, and Saskatchewan, Canada: relationship to drug insurance reimbursement policies. Am J Geriatric Pharmacother 2 (2004) 24-35
4. Beilby J., Marley J., Walker D., Chamberlain N., and Burke M. Effect of changes in antibiotic prescribing on patient outcomes in a community setting: a natural experiment in Australia. Clin Infect Dis 34 (2002) 55-64
5. Mandell L.A., Marrie T.J., Grossman R.F., Chow A.W., and Hyland R.H. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 31 (2000) 383-421
6. Mandell L.A., and Niederman M. Antimicrobial treatment of community acquired pneumonia in adults: a conference report. Can J Infect Dis 4 (1993) 25-28
7. Kozyrskyj A.L., and Mustard C.A. Validation of an electronic, population-based prescription database. Ann Pharmacother 32 (1998) 1152-1157
8. Roos L.L., Mustard C., Nichol J.P., et al. Registries and administrative data: organization and accuracy. Med Care 31 (1993) 201-212
9. Roos L.L., Roos N.P., Cageorge S.M., and Nichol J.P. How good are the data? Reliability of one health care data bank. Med Care 20 (1982) 266-276
10. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992) 613-619
11. Reid R., MacWilliams L., Roos N.P., Bogdanovic B., and Black C. Measuring morbidity in populations: performance of the John Hopkins Adjusted Clinical Group (ACG) Case-Mix System in Manitoba (1999), Manitoba Centre for Health Policy, Winnipeg, Canada
12. Mustard C.A., Derksen S., Berthelot J.-M., and Wolfson M. Assessing ecologic proxies for household income: a comparison of household and neighbourhood level income measures in the study of population health status. Health Place 5 (1999) 157-171
13. Laurichesse H., Gerbaud L., Baud O., Gourdon F., and Beytout J. Hospitalization decision for ambulatory patients with community-acquired pneumonia: a prospective study with general practitioners in France. Infection 29 (2001) 320-325
14. Laurichesse H., Sotto A., Bonnet E., et al. Pre- and in-hospital management of community-acquired pneumonia in southern France 1998-99. Eur J Clin Microbiol Infect Dis 20 (2001) 770-778
15. Jin Y., Marrie T.J., Carriere K.C., et al. Variation in management of community-acquired pneumonia requiring admission to Alberta, Canada hospitals. Epidemiol Infect 130 (2003) 41-51
16. Carrie A.G., Metge C.J., and Zhanel G.G. Antibiotic use in a Canadian Province, 1995-1998. Ann Pharmacother 34 (2000) 459-464
17. Kozyrskyj A.L., Carrie A.G., Mazowita G.B., Lix L.M., Klassen T.P., and Law B.J. Decrease in antibiotic use among children in the 1990s: not all antibiotics, not all children. CMAJ 171 (2004) 133-138
18. McCaig L.F. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 287 (2002) 3096-3102
19. McManus P., Hammond M.L., Whicker S.D., Primrose J.G., Mant A., and Fairall S.R. Antibiotic use in the Australian community, 1990-1995. Med J Aust 167 (1997) 124-127
20. McCombs J.S., and Nichol M.B. The use of first- and second-line outpatient antibiotics under the Saskatchewan Drug Plan. Pharmacoeconomics 7 (1995) 543-554
21. Straand J., Rokstad K., and Sandvik H. Prescribing systemic antibiotics in general practice. A report from the More and Romsdal Prescription Study. Scand J Prim Health Care 16 (1997) 121-127
22. Steinman M.A. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA 289 (2003) 719-725
23. Humphries K.H., Rankin J.M., Carere R.G., Buller C.E., Kiely F.M., and Spinelli J.J. Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review?. J Clin Epidemiol 53 (2000) 343-349
24. Shariatzadeh M.R., Huang J.Q., Tyrrell G.J., Johnson M.M., and Marrie T.J. Bacteremic pneumococcal pneumonia: a prospective study in Edmonton and neighboring municipalities. Medicine (Baltimore) 84 (2005) 147-161